HEMSOL-HC Drug Patent Profile
✉ Email this page to a colleague
When do Hemsol-hc patents expire, and when can generic versions of Hemsol-hc launch?
Hemsol-hc is a drug marketed by Able and is included in one NDA.
The generic ingredient in HEMSOL-HC is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HEMSOL-HC?
- What are the global sales for HEMSOL-HC?
- What is Average Wholesale Price for HEMSOL-HC?
Summary for HEMSOL-HC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Patent Applications: | 3,818 |
| DailyMed Link: | HEMSOL-HC at DailyMed |
US Patents and Regulatory Information for HEMSOL-HC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Able | HEMSOL-HC | hydrocortisone acetate | CREAM;TOPICAL | 081274-001 | Jun 19, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
